Patent Assignment
Reel/Frame 059145/0510
Assignment of Assignor's Interest
Recorded: 2022-03-02
Pages: 2
Assignor
UMC UTRECHT HOLDING B.V.
Executed: 2021-07-12
Assignee
SYNERKINE PHARMA B.V.
VAN HALL-LAAN 11, 1412 CS NAARDEN, NETHERLANDS
Covered Properties
(2)
Fusion Protein Comprising IL13
Therapeutic Crosslinking of Cytokine Receptors
Application:
17/504,045 →
Publication:
US 2022/0143145
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 2, 2021
From: EIJKELKAMP, NIELS; HACK, CORNELIS ERICK; PRADO SANCHEZ, JUDITH; POPOV-CELEKETIC, JELENA
To: UMC UTRECHT HOLDING B.V.
Reel/Frame 055806/0571 →
Confirmatory Assignment
Apr 2, 2021
From: UMC UTRECHT HOLDING B.V.
To: SYNERKINE PHARMA B.V.
Reel/Frame 055813/0832 →
Assignment of Assignor's Interest
Oct 18, 2021
From: EIJKELKAMP, NIELS; HACK, CORNELIS ERIK; SANCHEZ, JUDITH PRADO; SEBASTIAAN WESTERINK, REMCO HENRI
To: UMC UTRECHT HOLDING B.V.
Reel/Frame 057824/0469 →
Assignment of Assignor's Interest
Oct 18, 2021
From: UMC UTRECHT HOLDING B.V.
To: SYNERKINE PHARMA B.V.
Reel/Frame 057824/0524 →
Assignment of Assignor's Interest
Mar 2, 2022
From: UMC UTRECHT HOLDING B.V.
To: SYNERKINE PHARMA B.V.
Reel/Frame 059145/0488 →